CM
Caption Management Portfolio holdings
AUM
$1.09B
1-Year Return
4.13%
This Quarter Return
+0.25%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$569M
AUM Growth
-$541M
(-49%)
Cap. Flow
-$551M
Cap. Flow
% of AUM
-96.88%
Top 10 Holdings %
Top 10 Hldgs %
32.37%
Holding
1,023
New
229
Increased
81
Reduced
147
Closed
200
Top Buys
| 1 |
EQT Corp
EQT
|
+$21M |
| 2 |
Zoom
ZM
|
+$12.1M |
| 3 |
CANO
Cano Health, Inc.
CANO
|
+$7.15M |
| 4 |
Sabre
SABR
|
+$6.27M |
| 5 |
PING
Ping Identity Holding Corp.
PING
|
+$6.13M |
Top Sells
| 1 |
Diamondback Energy
FANG
|
+$57.8M |
| 2 |
Trip.com Group
TCOM
|
+$55.1M |
| 3 |
Devon Energy
DVN
|
+$41.2M |
| 4 |
Freeport-McMoran
FCX
|
+$34.3M |
| 5 |
X
US Steel
X
|
+$21.7M |
Sector Composition
| 1 | Energy | 25.74% |
| 2 | Healthcare | 19.23% |
| 3 | Technology | 11.5% |
| 4 | Materials | 11.15% |
| 5 | Consumer Discretionary | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Axos Financial
AX
$5.19B
| $67K | ﹤0.01% |
+1,981
| New | +$67K |
|
427
Nektar Therapeutics
NKTR
$891M
| $67K | ﹤0.01% |
1,400
-176
| -11% | -$8.42K |
|
428
Arbutus Biopharma
ABUS
$886M
| $64K | ﹤0.01% |
33,784
-17,016
| -33% | -$32.2K |
|
429
Genco Shipping & Trading
GNK
$767M
| $64K | ﹤0.01% |
5,000
| – | – |
|
430
StoneCo
STNE
$4.76B
| $62K | ﹤0.01% |
6,544
-95,306
| -94% | -$903K |
|
431
Zevra Therapeutics
ZVRA
$447M
| $62K | ﹤0.01% |
+10,000
| New | +$62K |
|
|
ATVI
432
DELISTED
Activision Blizzard Inc.
ATVI
| $60K | ﹤0.01% |
800
-49,200
| -98% | -$3.69M |
|
|
BNFT
433
DELISTED
Benefitfocus, Inc.
BNFT
| $59K | ﹤0.01% |
+9,322
| New | +$59K |
|
434
Ericsson
ERIC
$26.5B
| $58K | ﹤0.01% |
+10,000
| New | +$58K |
|
435
Exxon Mobil
XOM
$479B
| $58K | ﹤0.01% |
664
-2,536
| -79% | -$222K |
|
|
SRNE
436
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $57K | ﹤0.01% |
+36,892
| New | +$57K |
|
437
Macerich
MAC
$4.51B
| $56K | ﹤0.01% |
7,000
| – | – |
|
438
Wayfair
W
$11.2B
| $53K | ﹤0.01% |
1,600
-25,800
| -94% | -$855K |
|
439
Iovance Biotherapeutics
IOVA
$843M
| $52K | ﹤0.01% |
5,397
-32,003
| -86% | -$308K |
|
440
AbCellera Biologics
ABCL
$1.29B
| $51K | ﹤0.01% |
+5,134
| New | +$51K |
|
441
IHS Holding
IHS
$2.43B
| $51K | ﹤0.01% |
+9,000
| New | +$51K |
|
|
ROIVW
442
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
| $51K | ﹤0.01% |
126,856
| – | – |
|
443
Toast
TOST
$23.2B
| $50K | ﹤0.01% |
+2,973
| New | +$50K |
|
444
VistaGen Therapeutics
VTGN
$109M
| $50K | ﹤0.01% |
10,972
-278
| -2% | -$1.27K |
|
445
Legend Biotech
LEGN
$6.19B
| $49K | ﹤0.01% |
+1,210
| New | +$49K |
|
446
Cardinal Health
CAH
$35.9B
| $45K | ﹤0.01% |
676
-25,840
| -97% | -$1.72M |
|
447
FedEx
FDX
$53.4B
| $45K | ﹤0.01% |
+304
| New | +$45K |
|
448
NVIDIA
NVDA
$4.29T
| $45K | ﹤0.01% |
3,710
-426,760
| -99% | -$5.18M |
|
449
Financial Select Sector SPDR Fund
XLF
$54B
| $45K | ﹤0.01% |
+1,477
| New | +$45K |
|
450
Upstart Holdings
UPST
$5.93B
| $42K | ﹤0.01% |
2,000
| – | – |
|